Teladoc Health (TDOC) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
29 Oct, 2026Executive summary
Q3 revenue was $605.1M, down 3% YoY; net loss narrowed to $26.9M, or $0.15/share, while adjusted EBITDA rose 14% to $79.4M.
Integrated Care growth and higher insurance revenue partly offset BetterHelp cash-pay declines; results were near the high end of revenue guidance and above adjusted EBITDA guidance.
Financial highlights
Q3 adjusted EBITDA margin was 13.1%, versus 11.2% a year earlier; operating loss narrowed to $28.1M from $52.0M.
Q3 operating cash flow was $106.5M and free cash flow was $75.9M; nine-month free cash flow was $85.4M versus $113.5M.
Nine-month revenue declined 3% to $1.826B; net loss narrowed to $129.7M and adjusted EBITDA increased 3% to $203.2M.
Q3 advertising and marketing expense fell 26% to $124.0M, primarily due to lower BetterHelp digital and media spending.
Outlook and guidance
FY 2026 revenue guidance is $2,395M–$2,441M and adjusted EBITDA guidance is $277M–$303M; free cash flow guidance is $135M–$165M.
FY 2026 net loss per share guidance is $0.95–$0.75; Q4 revenue guidance is $569M–$615M, adjusted EBITDA is $74M–$100M, and net loss per share is $0.23–$0.03.
FY and Q4 U.S. Integrated Care member outlook is 99.5M–100.5M.
BetterHelp’s 2026 outlook was materially reduced; cash-pay declines are not expected to be fully offset by insurance revenue.
2027 BetterHelp goal: sequential quarterly insurance growth and an exit annualized revenue run rate of at least $200M; full-year advertising spend expected to decline in the mid-to-high 20% range.
Latest events from Teladoc Health
- Q2 2026 revenue fell 4% as BetterHelp declined 12% and net loss widened to $38.9 million.TDOC
Q2 2026 - Strategy centers on integrated care, mental health, global growth, and operational efficiency.TDOC
Goldman Sachs 46th Annual Global Healthcare Conference 2025 - All proposals, including director elections and auditor ratification, were approved by majority vote.TDOC
AGM 2026 - Q1 2026 revenue fell 2% to $613.8M, net loss narrowed, and full-year outlook reaffirmed.TDOC
Q1 2026 - Annual meeting covers director elections, say-on-pay, auditor ratification, and strong governance.TDOC
Proxy filing - Director elections, executive pay, and auditor ratification headline the 2026 annual meeting agenda.TDOC
Proxy filing - Strategic transformation and insurance expansion drive growth, with AI and M&A supporting future gains.TDOC
Barclays 28th Annual Global Healthcare Conference - Q3 2024 revenue fell 3% as BetterHelp declined, but Integrated Care showed growth.TDOC
Q3 2024 - Revenue and margin declined in 2024, with a major impairment and cautious 2025 outlook.TDOC
Q4 2024